Barclays PLC lifted its holdings in Delek US Holdings, Inc. (NYSE:DK - Free Report) by 51.5% during the third quarter, according to the company in its most recent filing with the SEC. The fund owned 1,496,825 shares of the oil and gas company's stock after buying an additional 508,719 shares during the quarter. Barclays PLC owned approximately 2.37% of Delek US worth $28,065,000 as of its most recent filing with the SEC.
Several other hedge funds and other institutional investors have also modified their holdings of DK. Quarry LP bought a new position in Delek US during the 2nd quarter worth $43,000. Farther Finance Advisors LLC grew its position in shares of Delek US by 24.2% during the third quarter. Farther Finance Advisors LLC now owns 7,733 shares of the oil and gas company's stock worth $145,000 after acquiring an additional 1,508 shares during the last quarter. Capstone Investment Advisors LLC acquired a new stake in shares of Delek US in the 3rd quarter worth about $193,000. Bailard Inc. acquired a new position in Delek US during the 2nd quarter valued at about $201,000. Finally, MQS Management LLC bought a new position in Delek US in the 3rd quarter worth about $201,000. 97.01% of the stock is owned by institutional investors and hedge funds.
Delek US Stock Down 0.6 %
Shares of NYSE DK traded down $0.11 during mid-day trading on Friday, reaching $17.45. The company had a trading volume of 773,354 shares, compared to its average volume of 1,071,236. The company has a debt-to-equity ratio of 3.18, a quick ratio of 0.67 and a current ratio of 1.04. The company has a market capitalization of $1.10 billion, a price-to-earnings ratio of -3.59 and a beta of 1.22. The stock has a fifty day moving average of $18.02 and a two-hundred day moving average of $20.64. Delek US Holdings, Inc. has a 12-month low of $15.36 and a 12-month high of $33.60.
Delek US (NYSE:DK - Get Free Report) last released its earnings results on Wednesday, November 6th. The oil and gas company reported ($1.45) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($1.71) by $0.26. Delek US had a negative net margin of 2.27% and a negative return on equity of 28.21%. The company had revenue of $3.04 billion during the quarter, compared to the consensus estimate of $3.23 billion. During the same quarter in the prior year, the firm earned $2.02 EPS. The company's revenue was down 34.3% compared to the same quarter last year. As a group, equities research analysts expect that Delek US Holdings, Inc. will post -4.4 EPS for the current year.
Delek US Dividend Announcement
The company also recently announced a quarterly dividend, which was paid on Monday, November 18th. Shareholders of record on Tuesday, November 12th were given a $0.255 dividend. This represents a $1.02 annualized dividend and a yield of 5.85%. The ex-dividend date of this dividend was Tuesday, November 12th. Delek US's payout ratio is currently -20.99%.
Analyst Upgrades and Downgrades
Several research firms have recently issued reports on DK. Morgan Stanley decreased their price target on Delek US from $24.00 to $22.00 and set an "underweight" rating for the company in a research note on Monday, September 16th. Piper Sandler lowered their target price on shares of Delek US from $25.00 to $19.00 and set a "neutral" rating on the stock in a research note on Friday, September 20th. Bank of America assumed coverage on shares of Delek US in a research note on Thursday, October 17th. They issued an "underperform" rating and a $15.00 price target for the company. StockNews.com lowered shares of Delek US from a "hold" rating to a "sell" rating in a research note on Saturday, September 21st. Finally, Scotiabank cut their target price on Delek US from $25.00 to $22.00 and set a "sector perform" rating for the company in a research report on Thursday, October 10th. Six investment analysts have rated the stock with a sell rating and six have issued a hold rating to the company's stock. Based on data from MarketBeat, the stock currently has an average rating of "Hold" and a consensus target price of $21.10.
Read Our Latest Stock Analysis on DK
About Delek US
(
Free Report)
Delek US Holdings, Inc engages in the integrated downstream energy business in the United States. The company operates through Refining, Logistics, and Retail segments. The Refining segment processes crude oil and other feedstock for the manufacture of various grades of gasoline, diesel fuel, aviation fuel, asphalt, and other petroleum-based products that are distributed through owned and third-party product terminal.
See Also
Before you consider Delek US, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Delek US wasn't on the list.
While Delek US currently has a "Reduce" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.